Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs

被引:0
作者
Cees J. Haagsma
机构
[1] Medisch Spectrum Twente,Department of Rheumatology
来源
Drugs & Aging | 1998年 / 13卷
关键词
Rheumatoid Arthritis; Methotrexate; Cyclosporin; Adis International Limited; Rheumatic Disease;
D O I
暂无
中图分类号
学科分类号
摘要
Rheumatic diseases are mostly chronic in nature and often require long term drug treatment. An increasing number of disease-modifying antirheumatic drugs (DMARDs) are used earlier in the course of disease and increasingly in combination with each other. Often there is comorbidity with ensuing pharmacotherapy, especially in the elderly, and therefore the risk of unwanted drug interactions increases. Awareness of these interactions is important in order to either avoid or manage them.
引用
收藏
页码:281 / 289
页数:8
相关论文
共 50 条
[31]   Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis [J].
Terabe, Kenya ;
Takahashi, Nobunori ;
Asai, Shuji ;
Hirano, Yuji ;
Kanayama, Yasuhide ;
Yabe, Yuichiro ;
Oguchi, Takeshi ;
Fujibayashi, Takayoshi ;
Ishikawa, Hisato ;
Hanabayashi, Masahiro ;
Hattori, Yosuke ;
Suzuki, Mochihito ;
Kishimoto, Kenji ;
Ohashi, Yoshifumi ;
Imaizumi, Takahiro ;
Imagama, Shiro ;
Kojima, Toshihisa .
MODERN RHEUMATOLOGY, 2023, 33 (02) :292-301
[32]   Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study [J].
Juan Mas, Antonio ;
Castaneda, Santos ;
Cantero Santamaria, Jose, I ;
Baquero, Jose L. ;
del Toro Santos, Francisco J. ;
de Miguel, Alegre ;
Castaneda Sanz, Cayetano ;
Castano Sanchez, Santos ;
Chamizo Carmona, Manuel ;
de Toro Santos, Eugenio ;
Garcia Aparicio, Francisco Javier ;
Garcia Fernandez, Angel Angel ;
Garmendia Sanchez, Maria Edilia ;
Hernandez Miguel, Elena ;
Hidalgo Calleja, Maria Victoria ;
Juan Mas, Cristina ;
Martinez Lopez, Antonio ;
Martinez Taboada, Juan Antonio ;
Monteagudo Saez, Victor ;
Naranjo Hernandez, Indalecio ;
One Martinez, Antonio ;
Perez Galan, Javier ;
Rodriguez Escalera, Maria Jose ;
Gomez de Salazar, Jose Carlos Rosas .
REUMATOLOGIA CLINICA, 2019, 15 (05) :264-270
[33]   Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia [J].
Palmsten, Kristin ;
Hernandez-Diaz, Sonia ;
Kuriya, Bindee ;
Solomon, Daniel H. ;
Setoguchi, Soko .
ARTHRITIS CARE & RESEARCH, 2012, 64 (11) :1730-1738
[34]   The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis [J].
Nuenninghoff, DM ;
Matteson, EL .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (06) :S29-S34
[35]   Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis [J].
Brooks, Lisbeth ;
Kivlin, William ;
Mohananey, Divyanshu ;
Sabchyshyn, Viktoriya ;
Putman, Michael .
RHEUMATOLOGY, 2025, 64 (06) :3303-3308
[36]   Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis [J].
Costa, Neide Tomimura ;
Veiga Iriyoda, Tatiana Mayumi ;
Alfieri, Daniela Frizon ;
Colado Simao, Andrea Name ;
Dichi, Isaias .
INFLAMMOPHARMACOLOGY, 2018, 26 (05) :1151-1164
[37]   Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients [J].
Joo, Young Bin ;
Jung, Seung Min ;
Park, Yune-Jung ;
Kim, Ki-Jo ;
Park, Kyung-Su .
JOURNAL OF RHEUMATIC DISEASES, 2022, 29 (03) :162-170
[38]   Clinical experience with combination disease-modifying antirheumatic drug therapy with cyclosporine [J].
Johns, K ;
Littlejohn, G .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) :S91-S94
[39]   Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis [J].
Emery, Paul ;
Sebba, Anthony ;
Huizinga, Tom W. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) :1897-1904
[40]   Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany [J].
Fassmer, Alexander M. ;
Garbe, Edeltraut ;
Schmedt, Niklas .
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (05)